Leaf extract of Rhus verniciflua Stokes protects dopaminergic neuronal cells in a rotenone model of Parkinson's disease

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 10, 2011, Pages 1358-1367

  Kim, Seung ^a   Park, Se Eun ^b   Sapkota, Kumar ^b,d   Kim, Myung Kon ^c   Kim, Sung Jun ^b  

^a Kwangju University   (South Korea)

^b Chosun University   (South Korea)

^c Chonbuk National University   (South Korea)

^d TRIBHUVAN UNIVERSITY   (Nepal)

Author keywords

apoptosis; dopaminergic cell; Parkinson's disease; Rhus verniciflua; rotenone

Indexed keywords

CASPASE 3; LACTATE DEHYDROGENASE; NEUROPROTECTIVE AGENT; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; RHUS VERNICIFLUA EXTRACT; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANACARDIACEAE; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE MODEL; DNA FRAGMENTATION; DOPAMINERGIC NERVE CELL; DRUG SCREENING; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL NECROSIS; NEUROPROTECTION; PARKINSON DISEASE; PLANT LEAF; PROTEIN EXPRESSION; RHUS VERNICIFLUA;

ANTIOXIDANTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL LINE; DOPAMINE; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PARKINSON DISEASE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; RHUS; ROTENONE; TYROSINE 3-MONOOXYGENASE;

EID: 80052591460     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01342.x     Document Type: Article

References (38)

1. Dawson TM, Dawson VL,. Neuroprotective and neurorestorative strategies for Parkinson's disease. Nat Neurosci 2002; 5: 1058-1061. (Pubitemid 35247199)
2. Sherer TB, et al,. Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease. J Neurochem 2007; 100: 1469-1479. (Pubitemid 46376213)
3. Betarbet R, et al,. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000; 3: 1301-1306.
4. Sherer TB, et al,. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol 2003; 179: 9-16. (Pubitemid 36062614)
5. Cannon JR, et al,. A highly reproducible rotenone model of Parkinson's disease. Neurobiol Dis 2009; 34: 279-290.
6. Kim TJ,. Korea Resource Plants, Vol. II. Seoul: Seoul National University Press, 1996.
7. Lee JC, et al,. Ethanol eluted extract of Rhus verniciflua Stokes showed both antioxidant and cytotoxic effects on mouse thymocytes depending on the dose and time of the treatment. J Biochem Mol Biol 2001; 34: 250-258.
8. Lim KT, et al,. Antioxidant activity of a Rhus verniciflua Stokes ethanol extract. Food Chem Toxicol 2001; 39: 229-237.
9. Kim IT, et al,. Anti-inflammatory and anti-nociceptive effects of the extract from Kalopanax pictus, Pueraria thenbergiana and Rhus verniciflua. J Ethnopharmacol 2004; 94: 165-173.
10. Kitts DD, Lim KT,. Antitumorigenic and cytotoxic properties of an ethanol extract derived from Rhus verniciflua Stokes (RVS). J Toxicol Environ Health A 2001; 64: 357-371. (Pubitemid 32989448)
11. Park BC, et al,. Protective effects of fustin, a flavonoid from Rhus verniciflua Stokes, on 6-hydroxydopamine-induced neuronal cell death. Exp Mol Med 2007; 39: 316-326.
12. Kim JH, et al,. Inhibition of the PI3K-Akt/PKB survival pathway enhanced an ethanol extract of Rhus verniciflua Stokes-induced apoptosis via a mitochondrial pathway in AGS gastric cancer cell lines. Cancer Lett 2008; 265: 197-205.
13. Lee SH, et al,. Impact of standardized Rhus verniciflua Stokes extract as complementary therapy on metastatic colorectal cancer: a Korean single-center experience. Integr Cancer Ther 2009; 8: 148-152.
14. Sapkota K, et al,. Effects of the detoxified extract of Rhus verniciflua on regulation of catecholamine biosynthesis. J Korean Soc Appl Biol Chem 2009; 52: 590-599.
15. Sapkota K, et al,. A detoxified extract of Rhus verniciflua Stokes upregulated the expression of BDNF and GDNF in the rat brain and the human dopaminergic cell line SH-SY5Y. Biosci Biotechnol Biochem 2010; 74: 1997-2004.
16. Sapkota K, et al,. Detoxified extract of Rhus verniciflua Stokes inhibits rotenone-induced apoptosis in human dopaminergic cells, SH-SY5Y. Cell Mol Neurobiol 2011; 31: 213-223.
17. Park KY, et al,. Antimutagenic activity of flavonoids from the heartwood of Rhus verniciflua. J Ethnopharmacol 2004; 90: 73-79.
18. Ko JH, et al,. 36-kDa glycoprotein isolated from Rhus verniciflua Stokes fruit has a protective activity to glucose/glucose oxidase-induced apoptosis in NIH/3T3 cells. Toxicol In Vitro 2005; 19: 353-363.
19. Choi HS, et al,. Biological detoxification of lacquer tree (Rhus verniciflua Stokes) stem bark by mushroom species. Food Sci Biotechnol 2007; 16: 935-942.
20. Hong MH, et al,. Early antiallergic inflammatory effects of Rhus verniciflua Stokes on human mast cells. Phytother Res 2010; 24: 288-294.
21. Park SD, et al,. Clinical features of 31 patients with systemic contact dermatitis due to the ingestion of Rhus (lacquer). Br J Dermatol 2000; 142: 937-942. (Pubitemid 30304604)
22. Chen LB,. Mitochondrial membrane potential in living cells. Annu Rev Cell Biol 1988; 4: 155-181. (Pubitemid 19139255)
23. Rahn CA, et al,. Assessment of mitochondrial membrane potential as an indicator of cytotoxicity. Fundam Appl Toxicol 1991; 16: 435-448.
24. Ubl JJ, et al,. A critical evaluation of in situ measurement of mitochondrial electrical potentials in single hepatocytes. Biochem Biophys Acta 1996; 1276: 124-132. (Pubitemid 26308728)
25. Prehn JH, et al,. Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons. Mol Pharmacol 1996; 49: 319-328. (Pubitemid 26066118)
26. Betarbet R, et al,. Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system. Neurobiol Dis 2006; 22: 404-420. (Pubitemid 44294281)
27. Jung CH, et al,. Phenolic-rich fraction from Rhus verniciflua Stokes (RVS) suppress inflammatory response via NF-kappaB and JNK pathway in lipopolysaccharide-induced RAW 264.7 macrophages. Ethnopharmacol 2007; 110: 490-497. (Pubitemid 46386364)
28. Lee DS, et al,. Anti-inflammatory effects of sulfuretin from Rhus verniciflua Stokes via the induction of heme oxygenase-1 expression in murine macrophages. Int Immunopharmacol 2010; 10: 850-858.
29. Hengartner MO,. The biochemistry of apoptosis. Nature 2000; 407: 770-776.
30. Borner C,. The bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 2003; 39: 615-647. (Pubitemid 35454076)
31. Chinnaiyan AM, et al,. Molecular ordering of the cell death pathway-Bcl-2 and Bcl-x (L) function upstream of ced-3-like apoptotic proteases. J Biol Chem 1996; 271: 4573-4576.
32. Nagatsu T, et al,. Tyrosine hydroxylase, the initial step in norepinephrine biosynthesis. J Biol Chem 1964; 239: 2910-2917.
33. Betarbet R, et al,. Mechanistic approaches to Parkinson's disease pathogenesis. Brain Pathol 2002; 12: 499-510. (Pubitemid 35154938)
34. Bove J, et al,. Toxin-induced models of Parkinson's disease. NeuroRx 2005; 2: 484-494. (Pubitemid 41444882)
35. Chen JF, et al,. Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation: implications for the treatment of dyskinesias in Parkinson's disease. Neurology 2003; 61: S74-S81.
36. Borges CR, et al,. Dopamine biosynthesis is regulated by S-glutathionylation. Potential mechanism of tyrosine hydroxylast inhibition during oxidative stress. J Biol Chem 2002; 277: 48295-48302. (Pubitemid 35470783)
37. Yu S, et al,. Alpha-synuclein and dopamine metabolism. Mol Neurobiol 2005; 31: 243-254.
38. Falk T, et al,. Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease. Mol Neurodegener 2009; 10: 4:49 doi:10.1186/1750-1326-4-49.